A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β: An Italian Sarcoma Group study.
Grignani
Giovanni
G
Medical Oncology Unit, Institute for Cancer Research and Treatment, Turin, Italy. giovanni.grignani@ircc.it
Palmerini
Emanuela
E
Stacchiotti
Silvia
S
Boglione
Antonella
A
Ferraresi
Virginia
V
Frustaci
Sergio
S
Comandone
Alessandro
A
Casali
Paolo G
PG
Ferrari
Stefano
S
Aglietta
Massimo
M